Imidazolidine compounds
AssigneesMillennium Pharmaceuticals, Inc., Kyowa Hakko Kogyo Co., Ltd.
InventorsEtsuo Ohshima, Hiroki Sone, Osamu Kotera, Jay R. Luly, Gregory J. LaRosa
Life of this patent
Estimating the term…
Abstract
Disclosed are novel compounds and a method of treating inflammatory diseases. The method comprises administering to an individual in need an effective amount of an imidazolidine compound represented by Structural Formula (I): 1 or a physiologically acceptable salt thereof.
Claims12
An imidazolidine compound represented by the following Formula (I):
- 111
- or a physiologically acceptable salt thereof, wherein:
- Z is
- hydrogen,
- halogen,
- hydroxy,
- —COOH,
- —CONH2,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted haloalkyl,
- substituted or unsubstituted heteroalkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted polycycloalkyl,
- substituted or unsubstituted lower alkenyl,
- substituted or unsubstituted cycloalkenyl,
- substituted or unsubstituted polycycloalkenyl,
- substituted or unsubstituted lower alkoxy,
- substituted or unsubstituted lower alkanoyloxy,
- substituted or unsubstituted lower alkanoyl,
- substituted or unsubstituted lower alkoxycarbonyl,
- substituted or unsubstituted aralkyl,
- substituted or unsubstituted heteroaralkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted heteroaryl, or
- a substituted or unsubstituted non-aromatic heterocyclic group, or
- Z and R6 taken together form a bond, or
- Z and R13a taken together form a bond;
- X1 and X2 are each, independently,
- hydrogen,
- —CN,
- —NO2,
- —SO2R15a,
- —SO2NR15aR15b,
- —C(═O)—R15a,
- —C(═O)—OR15a, or
- —C(═O)—NR15aR15b, wherein
- R15a and R15b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl, or
- substituted or unsubstituted aralkyl;
- Y is
- a bond,
- —(C═O)—, or
- —(CR16aR16b)—, wherein
- R16a and R16b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl, or
- substituted or unsubstituted aralkyl;
- R1 is
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted polycycloalkyl,
- substituted or unsubstituted lower alkenyl,
- substituted or unsubstituted cycloalkenyl,
- substituted or unsubstituted lower alkoxy,
- substituted or unsubstituted lower alkanoyloxy,
- substituted or unsubstituted aralkyl,
- substituted or unsubstituted heteroaralkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted heteroaryl, or
- a substituted or unsubstituted non-aromatic heterocyclic group;
- R2a, R2b, R3a, R3b, R4a, R4b, R5a, and R5b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl, or
- substituted or unsubstituted heteroaralkyl;
- R6, R7, R8, and R9 are each, independently,
- hydrogen,
- hydroxy,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted lower alkoxy,
- substituted or unsubstituted lower alkanoyl,
- substituted or unsubstituted lower alkanoyloxy,
- substituted or unsubstituted lower alkoxycarbonyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted heteroaryl,
- halogen,
- —CN,
- —NO2,
- —C(═O) OR17a,
- —NR17aR17b, or
- —C(═O)—NR17aR17b, wherein
- R17a and R17b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl, or
- substituted or unsubstituted aralkyl, or
- R17a and R17b taken together with the nitrogen atom to which they are bonded form a substituted or unsubstituted heterocyclic group containing at least one nitrogen atom;
- R10a, R10b, R11a, and R11b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl,
- substituted or unsubstituted heteroaralkyl, or
- substituted or unsubstituted lower alkoxyalkyl;
- R12a and R12b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl, or
- substituted or unsubstituted heteroaralkyl, or
- R12a and R12b taken together with the nitrogen atom to which they are bonded form a substituted or unsubstituted heterocyclic group containing at least one nitrogen atom;
- R13a and R13b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl, or
- substituted or unsubstituted heteroaralkyl,
- wherein when p is 2 or more, multiple R13a's are independently the same or different and multiple R13b's are independently the same or different;
- m is an integer from 0 to 4;
- n is an integer from 0 to 6;
- p is an integer from 0 to 9;
- and
- q is an integer from 0 to 5
A method of inhibiting inflammation in an individual, comprising administering to the individual a therapeutically effective amount of an imidazolidine compound represented by the following Formula (I):
- 112
- or a physiologically acceptable salt thereof, wherein:
- Z is
- hydrogen,
- halogen,
- hydroxy,
- —COOH,
- —CONH2,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted haloalkyl,
- substituted or unsubstituted heteroalkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted polycycloalkyl,
- substituted or unsubstituted lower alkenyl,
- substituted or unsubstituted cycloalkenyl,
- substituted or unsubstituted polycycloalkenyl,
- substituted or unsubstituted lower alkoxy,
- substituted or unsubstituted lower alkanoyloxy,
- substituted or unsubstituted lower alkanoyl,
- substituted or unsubstituted lower alkoxycarbonyl,
- substituted or unsubstituted aralkyl,
- substituted or unsubstituted heteroaralkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted heteroaryl, or
- a substituted or unsubstituted non-aromatic heterocyclic group, or
- Z and R6 taken together form a bond, or
- Z and R13a taken together form a bond;
- X1 and X2 are each, independently,
- hydrogen,
- —CN,
- —NO2,
- —SO2R15a,
- —SO2NR15aR15b,
- —C(═O)—R15a,
- —C(═O)—OR15a, or
- —C(═O)—NR15aR15b, wherein
- R15a and R15b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl, or
- substituted or unsubstituted aralkyl;
- Y is
- a bond,
- —(C═O)—, or
- —(CR16aR16b)—, wherein
- R16a and R16b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl, or
- substituted or unsubstituted aralkyl;
- R1 is
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted polycycloalkyl,
- substituted or unsubstituted lower alkenyl,
- substituted or unsubstituted cycloalkenyl,
- substituted or unsubstituted lower alkoxy,
- substituted or unsubstituted lower alkanoyloxy,
- substituted or unsubstituted aralkyl,
- substituted or unsubstituted heteroaralkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted heteroaryl, or
- a substituted or unsubstituted non-aromatic heterocyclic group;
- R2aR2bR3aR3bR4aR4b, R5a and R5b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl, or
- substituted or unsubstituted heteroaralkyl;
- R6, R7, R8, and R9 are each, independently,
- hydrogen,
- hydroxy,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted lower alkoxy,
- substituted or unsubstituted lower alkanoyl,
- substituted or unsubstituted lower alkanoyloxy,
- substituted or unsubstituted lower alkoxycarbonyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted heteroaryl,
- halogen,
- —CN,
- —NO2,
- —C(═O)—OR17a,
- —NR17aR17b, or
- —C(═O)—NR17aR17b, wherein
- R17a and R17b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl, or
- substituted or unsubstituted aralkyl, or
- R17a and R17b taken together with the nitrogen atom to which they are bonded form a substituted or unsubstituted heterocyclic group containing at least one nitrogen atom;
- R10a, R10b, R11a, and R11b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl,
- substituted or unsubstituted heteroaralkyl, or
- substituted or unsubstituted lower alkoxyalkyl;
- R12a and R12b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl, or
- substituted or unsubstituted heteroaralkyl, or
- R12a and R12b taken together with the nitrogen atom to which they are bonded form a substituted or unsubstituted heterocyclic group containing at least one nitrogen atom;
- R13a and R13b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl, or
- substituted or unsubstituted heteroaralkyl,
- wherein when p is 2 or more, multiple R13a's are independently the same or different and multiple R13b's are independently the same or different;
- m is an integer from 0 to 4;
- n is an integer from 0 to 6;
- p is an integer from 0 to 9;
- and
- q is an integer from 0 to 5
A method of treating an individual having a disease associated with pathogenic leukocyte recruitment and/or activation, comprising administering to the individual a therapeutically effective amount of an imidazolidine compound represented by the following Formula (I):
- 113
- or a physiologically acceptable salt thereof, wherein
- Z is
- hydrogen,
- halogen,
- hydroxy,
- —COOH,
- —CONH2,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted haloalkyl,
- substituted or unsubstituted heteroalkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted polycycloalkyl,
- substituted or unsubstituted lower alkenyl,
- substituted or unsubstituted cycloalkenyl,
- substituted or unsubstituted polycycloalkenyl,
- substituted or unsubstituted lower alkoxy,
- substituted or unsubstituted lower alkanoyloxy,
- substituted or unsubstituted lower alkanoyl,
- substituted or unsubstituted lower alkoxycarbonyl,
- substituted or unsubstituted aralkyl,
- substituted or unsubstituted heteroaralkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted heteroaryl, or
- a substituted or unsubstituted non-aromatic heterocyclic group, or
- Z and R6 taken together form a bond, or
- Z and R13a taken together form a bond;
- X1 and X2 are each, independently,
- hydrogen,
- —CN,
- —NO2,
- —SO2R15a,
- —SO2NR15aR15b,
- —C(═O)—R15a,
- —C(═O)—OR15a, or
- —C(═O)—NR15aR15b, wherein
- R15a and R15b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl, or
- substituted or unsubstituted aralkyl;
- Y is
- a bond,
- —(C═O)—, or
- (CR16aR16b)—, wherein
- R16a and R16b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl, or
- substituted or unsubstituted aralkyl;
- R1 is
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted polycycloalkyl,
- substituted or unsubstituted lower alkenyl,
- substituted or unsubstituted cycloalkenyl,
- substituted or unsubstituted lower alkoxy,
- substituted or unsubstituted lower alkanoyloxy,
- substituted or unsubstituted aralkyl,
- substituted or unsubstituted heteroaralkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted heteroaryl, or
- a substituted or unsubstituted non-aromatic heterocyclic group;
- R2a, R2b, R3a, R3b, R4a, R4b, R5a, and R5b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl, or
- substituted or unsubstituted heteroaralkyl;
- R6, R7, R8, and R9 are each, independently,
- hydrogen,
- hydroxy,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted lower alkoxy,
- substituted or unsubstituted lower alkanoyl,
- substituted or unsubstituted lower alkanoyloxy,
- substituted or unsubstituted lower alkoxycarbonyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted heteroaryl,
- halogen,
- —CN, —C(═O)—OR17a,
- —NR17aR17a, or
- —C(═O)—NR17aR17b, wherein
- R17a and R17b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl, or
- substituted or unsubstituted aralkyl, or
- R17a and R17b taken together with the nitrogen atom to which they are bonded form a substituted or unsubstituted heterocyclic group containing at least one nitrogen atom;
- R10a, R10b, R11a, and R11b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl,
- substituted or unsubstituted heteroaralkyl, or
- substituted or unsubstituted lower alkoxyalkyl;
- R12a and R12b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl, or
- substituted or unsubstituted heteroaralkyl, or
- R12a and R12b taken together with the nitrogen atom to which they are bonded form a substituted or unsubstituted heterocyclic group containing at least one nitrogen atom;
- R13a and R13b are each, independently,
- hydrogen,
- substituted or unsubstituted lower alkyl,
- substituted or unsubstituted cycloalkyl,
- substituted or unsubstituted aryl,
- substituted or unsubstituted aralkyl, or
- substituted or unsubstituted heteroaralkyl,
- wherein when p is 2 or more, multiple R13a's are independently the same or different and multiple R13b's are independently the same or different;
- m is an integer from 0 to 4;
- n is an integer from 0 to 6;
- p is an integer from 0 to 9;
- and
- q is an integer from 0 to 5
Dependencies are inferred from the claim text.